Literature DB >> 32713412

Mexico and the COVID-19 Response.

Ismael Ibarra-Nava1, Jesús A Cardenas-de la Garza2, Raul E Ruiz-Lozano3, Raul G Salazar-Montalvo1.   

Abstract

Mexico has been one of the most affected countries in the world by the COVID-19 pandemic. The true impact of the pandemic has probably been underestimated, and President López Obrador, as well as the Ministry of Health, has struggled to lead the country since the beginning. While cases and deaths continue to rise, stronger leadership and unity are needed to limit the impact of COVID-19 on the health of millions of Mexicans.

Entities:  

Keywords:  COVID-19; Mexico; coronavirus; leadership; pandemics; public health response; sentinel surveillance

Year:  2020        PMID: 32713412      PMCID: PMC7445449          DOI: 10.1017/dmp.2020.260

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


Recently, the World Health Organization declared Latin America as the new epicenter of the COVID-19 pandemic. In Mexico, the first COVID-19 cases were confirmed by the government on February 28. As of July 12, Mexico had one of the highest numbers of confirmed cases and deaths (299 759 and 35 006, respectively) in the region, and these are probably highly underestimated as Mexico has one of the lowest testing rates worldwide.[1] To make matters worse, of the total of reported cases and deaths so far, 70% of new cases and 72% of new deaths have been reported since June 1.[1] This acceleration over the past 2 months is not surprising as pressure to reopen the economy has resulted in less confinement restrictions across the country. Mexico’s COVID-19 response, however, has been controversial and criticized since the beginning of the outbreak. Mexico has implemented a sentinel epidemiological surveillance system, instead of a massive testing strategy, to count and report cases. In the beginning of May, the Ministry of Health estimated that approximately 104 562 people have had COVID-19, but the actual number of confirmed reported cases was 23 471.[2] This number was estimated using mathematical models from a sample, but data scientists and statisticians criticized the lack of transparency of the methodology used to provide these estimates.[3] Over a month has passed since those estimates were provided for the last time. With over 200 000 confirmed cases as of today, the true impact of COVID-19 might be highly underestimated by the general population, who recently seemed to have resumed normal life. But perhaps what is most worrisome is the questionable leadership from President Andrés Manuel López Obrador. Since the COVID-19 pandemic reached Mexico back in February, President López Obrador has minimized the pandemic’s potential impact on the health of millions of Mexicans. Initially, he continued to hold massive gatherings across Mexico as part of a presidential tour. He eventually stopped for some months, but he resumed them in early June as part of his plan to reopen the economy.[4] Despite his own government’s recommendation to use face masks, López Obrador continues to appear in press conferences and videos surrounded by people and in closed spaces without wearing one. In the most recent controversy, he said that “not lying, not stealing, and not betraying” helps prevent COVID-19 infections, raising questions of whether he’s more concerned about pushing his political agenda than he is about the actual pandemic.[5] Finally, López Obrador also criticized medical doctors and accused many of them of wanting to earn more money from practicing medicine rather than to help people, which spurred backlash from the medical community and has been the target of violent attacks amid growing unrest and paranoia from the general population.[6,7] Millions of Mexicans, including health care professionals working with scarce resources, have shown strong resilience and solidarity amid an unprecedented pandemic. However, stronger leadership from the highest level of government is crucially needed to avert more cases and deaths from COVID-19. Mexicans, as well as local, state, and federal governments, must work together with unprecedented efforts in order to drastically change the course of this pandemic, which has already taken thousands of vulnerable lives.
  11 in total

Review 1.  An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic.

Authors:  Julian W Tang; Miguela A Caniza; Mike Dinn; Dominic E Dwyer; Jean-Michel Heraud; Lance C Jennings; Jen Kok; Kin On Kwok; Yuguo Li; Tze Ping Loh; Linsey C Marr; Eva Megumi Nara; Nelun Perera; Reiko Saito; Carlos Santillan-Salas; Sheena Sullivan; Matt Warner; Aripuanã Watanabe; Sabeen Khurshid Zaidi
Journal:  Interface Focus       Date:  2022-02-11       Impact factor: 3.906

Review 2.  Mental Health Impact of the COVID-19 Pandemic on Mexican Population: A Systematic Review.

Authors:  Yazmín Hernández-Díaz; Alma Delia Genis-Mendoza; Miguel Ángel Ramos-Méndez; Isela Esther Juárez-Rojop; Carlos Alfonso Tovilla-Zárate; Thelma Beatriz González-Castro; María Lilia López-Narváez; Humberto Nicolini
Journal:  Int J Environ Res Public Health       Date:  2022-06-06       Impact factor: 4.614

3.  Populist Nationalism Threatens Health and Human Rights in the COVID-19 Response.

Authors:  Caitlin R Williams; Jocelyn Getgen Kestenbaum; Benjamin Mason Meier
Journal:  Am J Public Health       Date:  2020-10-29       Impact factor: 9.308

4.  Grace Under Pressure: Resiliency of Quality Monitoring of Stroke Care During the Covid-19 Pandemic in Mexico City.

Authors:  Raul Medina-Rioja; Gina González-Calderón; Sergio Saldívar-Dávila; Alexander Estrada Saúl; Erika Gayón-Lombardo; Nicole Somerville-Briones; Juan Manuel Calleja-Castillo
Journal:  Front Neurol       Date:  2022-04-06       Impact factor: 4.086

5.  Another Vision of the Situation of the COVID-19 Pandemic in Mexico During 2020.

Authors:  Sergio Isaac De La Cruz-Hernández
Journal:  Disaster Med Public Health Prep       Date:  2021-11-25       Impact factor: 1.385

6.  Real-world evidence of the use of glucocorticoids for severe COVID-19.

Authors:  Alejandra Albarrán-Sánchez; Claudia Ramírez-Rentería; Moisés Mercado; Miriam Sánchez-García; Corazón de Jesús Barrientos-Flores; Aldo Ferreira-Hermosillo
Journal:  Ther Adv Endocrinol Metab       Date:  2022-01-19       Impact factor: 3.565

7.  Transplant trends in Mexico during the COVID-19 pandemic: Disparities within healthcare sectors.

Authors:  Maximiliano Servin-Rojas; Antonio Olivas-Martinez; Fernando Ramirez Del Val; Armando Torres-Gomez; Luis Navarro-Vargas; Ignacio García-Juárez
Journal:  Am J Transplant       Date:  2021-09-15       Impact factor: 9.369

8.  Impact on the Nutritional and Functional Status of Older Mexican Adults in the Absence of Recreational Activities due to COVID-19: A Longitudinal Study From 2018 to 2021.

Authors:  Jaime Alberto Bricio-Barrios; Mónica Ríos-Silva; Miguel Huerta; Rosa Yolitzy Cárdenas-María; Alondra Elizabeth García-Ibáñez; María Guadalupe Díaz-Mendoza; Héctor Mariano Jiménez-Leal; Liz Argelia Chávez-Torres; Liliana Islas-Piza; Shelem García-García; Mario Del Toro-Equihua; Ricardo García-Rodríguez; Karla Berenice Carrazco-Peña; Fátima López-Alcaraz; Xóchitl Trujillo
Journal:  J Appl Gerontol       Date:  2022-05-03

9.  Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico.

Authors:  César Arturo Méndez-Lizárraga; MLucía Castañeda-Cediel; Guadalupe Delgado-Sánchez; Edith Elizabeth Ferreira-Guerrero; Leticia Ferreyra-Reyes; Sergio Canizales-Quintero; Norma Mongua-Rodríguez; Norma Tellez-Vázquez; María Eugenia Jiménez-Corona; Kathryn Bradford Vosburg; Omar Y Bello-Chavolla; Lourdes García-García
Journal:  Front Public Health       Date:  2022-08-04

10.  Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020.

Authors:  Amna Tariq; Juan M Banda; Pavel Skums; Sushma Dahal; Carlos Castillo-Garsow; Baltazar Espinoza; Noel G Brizuela; Roberto A Saenz; Alexander Kirpich; Ruiyan Luo; Anuj Srivastava; Humberto Gutierrez; Nestor Garcia Chan; Ana I Bento; Maria-Eugenia Jimenez-Corona; Gerardo Chowell
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.